-transparent.png){kind=logo}
Constant infusions of [13C]leucine and [2H5]phenylalanine were used to trace leucine and protein kinetics, respectively, in seven children with maple syrup urine disease (MSUD) and eleven controls matched for age and dietary protein intake. Despite significant elevations of plasma leucine (mean 351 mumol/l, range 224-477) in MSUD subjects, mean whole body protein synthesis [3.78 +/- 0.42 (SD) g.kg-1. 24 h-1] and catabolism (4.07 +/- 0.46) were similar to control values (3.69 +/- 0.50 and 4.09 +/- 0.50, respectively). The relationship between phenylalanine and leucine fluxes was also similar in MSUD subjects (mean phenylalanine-leucine flux ratio 0.35 +/- 0.07) and previously reported adult controls (0.33 +/- 0.02). Leucine oxidation was undetectable in four of the MSUD subjects and very low in the other three (less than 4 mumol.kg-1.h-1; controls 13-20). These results show that persistent elevation in leucine concentration has no effect on protein synthesis. The marked disturbance in leucine metabolism in MSUD did not alter the relationship between rates of catabolism of protein to phenylalanine and leucine, which provides further support for the validity of the use of a single amino acid to trace whole body protein metabolism. The minimal leucine oxidation in MSUD differs from findings in other inborn metabolic errors and indicates that in patients with classical MSUD there is no significant route of leucine disposal other than through protein synthesis.
G N Thompson, and
J L Bresson, and
P J Pacy, and
J P Bonnefont, and
J H Walter, and
J V Leonard, and
J M Saudubray, and
D Halliday
May 1975,
Srpski arhiv za celokupno lekarstvo,
G N Thompson, and
J L Bresson, and
P J Pacy, and
J P Bonnefont, and
J H Walter, and
J V Leonard, and
J M Saudubray, and
D Halliday
May 1966,
Die Medizinische Welt,
G N Thompson, and
J L Bresson, and
P J Pacy, and
J P Bonnefont, and
J H Walter, and
J V Leonard, and
J M Saudubray, and
D Halliday
July 1971,
The Proceedings of the Institute of Medicine of Chicago,
G N Thompson, and
J L Bresson, and
P J Pacy, and
J P Bonnefont, and
J H Walter, and
J V Leonard, and
J M Saudubray, and
D Halliday
March 1959,
Canadian Medical Association journal,
G N Thompson, and
J L Bresson, and
P J Pacy, and
J P Bonnefont, and
J H Walter, and
J V Leonard, and
J M Saudubray, and
D Halliday
April 2002,
Nihon rinsho. Japanese journal of clinical medicine,
G N Thompson, and
J L Bresson, and
P J Pacy, and
J P Bonnefont, and
J H Walter, and
J V Leonard, and
J M Saudubray, and
D Halliday
January 1970,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
G N Thompson, and
J L Bresson, and
P J Pacy, and
J P Bonnefont, and
J H Walter, and
J V Leonard, and
J M Saudubray, and
D Halliday
December 1967,
Journal of mental deficiency research,
G N Thompson, and
J L Bresson, and
P J Pacy, and
J P Bonnefont, and
J H Walter, and
J V Leonard, and
J M Saudubray, and
D Halliday
February 1993,
Deutsche Krankenpflegezeitschrift,
G N Thompson, and
J L Bresson, and
P J Pacy, and
J P Bonnefont, and
J H Walter, and
J V Leonard, and
J M Saudubray, and
D Halliday
March 1968,
Proceedings of the Royal Society of Medicine,
G N Thompson, and
J L Bresson, and
P J Pacy, and
J P Bonnefont, and
J H Walter, and
J V Leonard, and
J M Saudubray, and
D Halliday
January 2001,
Ryoikibetsu shokogun shirizu,
